Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

Melatonin, a hormone derived from the pineal gland, has diverse effects on cellular processes. This review explores its potential role as an epigenetic regulator, particularly in modulating DNA methylation, and suggests its use in combination therapy as a novel anticancer strategy.

30 May 2023

ENDO 2023 news conferences to highlight latest research in diabetes, obesity, reproductive health

Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society's ENDO 2023 news conferences June 15-18.

30 May 2023

One-day keto diet boosts energy expenditure, exogenous ketones have little effect

Research aims to compare the effects of a one-day isocaloric ketogenic diet, fasting, and supplementation with ketone salts on energy expenditure and appetite perception. The study found that a 24-hour ketogenic diet may contribute to maintaining a neutral energy balance by increasing energy expenditure.

29 May 2023

Gene expression signature associated with rapid progression of type 1 diabetes

Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the progression of type 1 diabetes.

29 May 2023

Passing on Polycystic Ovary Syndrome: Health risks for Male offspring of Women with PCOS

In this interview, we spoke to two researchers from the Karolinska Institutet about their latest work that investigated how PCOS can affect the health of future generations of men.

29 May 2023

Japanese natto consumption may help realize a healthy and longer-living society

Health is wealth as the saying goes and new research now shows that it is possible to have a healthy, less stressed society through familiar and inexpensive foods.

26 May 2023

Do glucose-lowering medications have different effects on kidney outcomes?

Researchers evaluated the kidney outcomes in individuals with type 2 diabetes.

26 May 2023

Plant-based diets can play a significant role in reducing blocked arteries, study says

Vegetarian and vegan diets are linked to lower levels of cholesterol and fats in your blood, according to an analysis of all the evidence from randomized trials published since 1982.

25 May 2023

New review unravels phthalates’ role in heart disease

Researchers review existing data on the impact of phthalate exposure on cardiovascular health.

25 May 2023

Targeting stem cells from the human stomach for treating diabetes

Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a preclinical study from researchers at Weill Cornell Medicine.

25 May 2023

$Is prediabetes associated with increased fracture risk among midlife women?$

Is prediabetes associated with increased fracture risk among midlife women?

Studying the correlation between prediabetes before the menopause and increased fracture risk.

25 May 2023

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Catherine Reitzel's multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies on a drug for a blood-clotting disorder that runs $10,000 for a three-day supply. And Mariana Marquez-Farmer would likely die within days without her monthly $300 vial of insulin.

25 May 2023

Study maps cellular responses to blood sugar

Researchers at The University of Texas at El Paso have successfully mapped specific regions in the brain that are activated in association with changes in blood sugar -; also known as glucose -; providing fundamental location information that could ultimately lead to more targeted therapies for people who struggle with conditions like diabetes.

25 May 2023

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

A study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher risk of developing cardiovascular disease, heart attack or atrial fibrillation (AFib), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

24 May 2023

Keto vs. low-fat diets: which is more sustainable in the long term?

Researchers investigated whether commercial weight loss diets meet nutrient requirements.

24 May 2023

Investigating the interplay between white blood cell count and incidence of hyper-low-density lipoprotein cholesterolemia

Researchers investigating the association between white blood cell count and LDL hypercholesteremia.

24 May 2023

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.

24 May 2023

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Research investigates the effectiveness of oral antiviral medications, Molnupiravir and Nirmatrelvir-Ritonavir, in treating patients with type 2 diabetes and mild to moderate COVID-19. The study aims to determine the efficacy of these medications in reducing adverse outcomes in this specific population.

24 May 2023

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas-;a wearable, pocket-sized, automated insulin delivery device-;that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year.

23 May 2023

Insulin News and Research

Further Reading

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

ENDO 2023 news conferences to highlight latest research in diabetes, obesity, reproductive health

One-day keto diet boosts energy expenditure, exogenous ketones have little effect

Gene expression signature associated with rapid progression of type 1 diabetes

Passing on Polycystic Ovary Syndrome: Health risks for Male offspring of Women with PCOS

Japanese natto consumption may help realize a healthy and longer-living society

Do glucose-lowering medications have different effects on kidney outcomes?

Plant-based diets can play a significant role in reducing blocked arteries, study says

New review unravels phthalates’ role in heart disease

Targeting stem cells from the human stomach for treating diabetes

Is prediabetes associated with increased fracture risk among midlife women?

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Study maps cellular responses to blood sugar

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

Keto vs. low-fat diets: which is more sustainable in the long term?

Investigating the interplay between white blood cell count and incidence of hyper-low-density lipoprotein cholesterolemia

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Latest News